We have to weave biology & technology into the DNA of U.S. national security.
We've been preparing tools and resources to support the medical community as well as decision makers, technologists, and other stakeholders to help understand, manage, and respond to COVID-19.
B.Next illuminates the national security implications of infectious disease outbreaks through thought leadership, proof-of-concept experimentation, and informing IQT investment strategy. We are building a trusted network linking government, academia, civil society, and private sector innovators.
Articles Feed - Homepage
IQT Roundtable: Capabilities Required for Pandemic Response
On August 12, 2021, In-Q-Tel (IQT) convened a virtual Roundtable meeting to examine the technologies used to respond to the Covid-19 pandemic and other epidemics, to discuss what needed capabilities were missing from the Covid response, and how these critical needs might be addressed. Roundtable participants included experts drawn from several United States government (USG) agencies, academia, private-sector technology companies, and members of the IQT/B.Next team. This paper provides background and details high-level takeaways from this important Roundtable discussion.
B.Next COVID-19 Test Database
This database is a tool for those who need to quickly obtain information about COVID-19 test kits and services for use in the United States. The database includes molecular tests that have received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA), whether they are kits that can be purchased by lab managers, or tests performed as a service by laboratories, whether sourced from manufacturers, or developed for their own use (so called laboratory-developed tests, or LDTs).
What We're Reading
Academic, private, and government institutions all produce meaningful research on an ongoing basis. Here are a few articles, books, and websites that capture some important perspectives on biodefense.